Bain Capital Private Equity
Bain Capital Private Equity pioneered the value-added investment approach, partnering with management teams around the world to accelerate growth through strategic and operational transformation. The firm invests across sectors including consumer, healthcare, industrials, services, and technology.
36% of their portfolio is in Healthcare. Average disclosed round size is $201.0M (across 7 rounds with reported amounts).
Portfolio
11
Fund Size
$11.8B
Top Stage
Unknown
Last 12 Mo
1
Team
Chris An
Managing Director
Emily Ashworth
Managing Director
Eric Anderson
Managing Director
Nicholas Bendt
Managing Director
Saahil Bhatia
Managing Director
Anthony MinGyu Bae
Partner
James Bath
Operating Partner
John Belitsos
Partner
Luca Bassi
Partner
Maria Andrisani
Partner
Ankit Aggarwal
Principal
Hannah Bend
Vice President
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| KKailera | Series B | $600M | Oct 2025 |
 Cardurion Pharmaceuticals | Series B | $260M | Jul 2024 |
| BBrillio | Unknown | — | Sep 2023 |
 PULSEDATA | Series A | $16.5M | Jan 2021 |
 Linc'well | Series C | $69.7M | May 2019 |
 Applied Systems | Growth | — | Oct 2018 |
| SSundial Brands | Unknown | — | Sep 2015 |
| CCerevel Therapeutics | Unknown | $350M | — |
 Kestra Medical Technologies | Bridge | — | — |
| LLincwell | Series C | $69.7M | — |
 QuVa Pharma | Growth | $41M | — |
Top Co-Investors
Last updated: 8 September 2026